Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Signs Option for Gene Solutions' Parkinson's Mutations

NEW YORK (GenomeWeb News) – Transgenomic yesterday said that it has signed a licensing option agreement with Gene Solutions for a set of validated mutations that can form the basis of a diagnostic test for Parkinson's disease.

Under the agreement, the companies will evaluate the ability of Transgenomic's mitochondrial mutation-detection technology to detect and quantify the presence of the mutations – low-level mitochondrial DNA, or mtDNA, variants that have been shown to be present in Parkinson's disease patients but rarely in age-matched control individuals.

The specific mtDNA variants are present at very low levels, in the range of 1 percent of mtDNA molecules, making them very difficult to identify with current mutation-detection methods, Transgenomic said.

"Transgenomic has historically been focused on high-sensitivity mutation detection and more recently we have developed a strong mitochondrial DNA mutation service in our CLIA-certified laboratory," Transgenomic CEO Craig Tuttle said in a statement. "As a result, there is an extremely natural fit with Gene Solutions' Parkinson's disease mutations discovery and an exciting commercial opportunity to transform this observation into a powerful and necessary diagnostic product."

Transgenomic, based in Omaha, Neb., also said that it sees the potential to apply COLD-PCR technology, which it recently licensed from the Dana Farber Cancer Institute, to use for mitochondrial DNA mutation enrichment and detection.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.